排斥反应是同种器官移植的难题。自八十年代出现新一代免疫抑制剂——环孢素A以来,学者们认为此药将临床器官移植推入到一个新的时期,但使用环孢素A仍有20％左右的病人在一年内因急性排斥反应丧失移植肾。因此,继续探索新的免疫抑制剂和新的联合用药方案,减少急性排斥反应发生率是急待解决的问题。我所根据在恒河猴体内 Rejection is the same kind of organ transplantation problem. Since the emergence of a new generation of immunosuppressant cyclosporin A in the 1980s, scholars believe the drug has pushed clinical organ transplants to a new era, but about 20% of cyclosporine A patients remain in a single During the year due to acute rejection loss of renal graft. Therefore, to continue to explore new immunosuppressive agents and new combination regimens, to reduce the incidence of acute rejection is an urgent problem. I’m based on rhesus monkeys